Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.022 | 0.6 |
mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.068 | 0.7 |
mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |